Solid Biosciences Provides Second Quarter 2022 Business Update and Financial ResultsGlobeNewsWire • 08/11/22
Solid Biosciences Reports Inducement Grant to New Senior Vice President, QualityGlobeNewsWire • 06/02/22
Solid Biosciences Inc. (SLDB) CEO Ilan Ganot on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 04/30/22
Solid Biosciences Announces Updated Corporate Strategy to Develop SGT-001 and SGT-003 Pipeline Programs for Patients with Duchenne Muscular DystrophyGlobeNewsWire • 04/27/22
Solid Biosciences Posts Two-Year Efficacy, Safety Data From Duchenne Gene Therapy TrialBenzinga • 03/14/22
Solid Biosciences Inc. (SLDB) Reports Q4 Loss, Lags Revenue EstimatesZacks Investment Research • 03/14/22
Solid Biosciences Reports Fourth Quarter and Full-Year 2021 Financial Results and 2-Year Efficacy and Safety Data from the Ongoing Phase I/II IGNITE DMD Clinical Trial of SGT-001GlobeNewsWire • 03/14/22
Solid Biosciences to Participate at the SVB Leerink 11th Annual Global Healthcare ConferenceGlobeNewsWire • 02/10/22
Solid Biosciences to Present at 40th Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/06/22
All You Need to Know About Solid Biosciences Inc. (SLDB) Rating Upgrade to BuyZacks Investment Research • 01/05/22
Solid Biosciences Inc. (SLDB) Reports Q3 Loss, Tops Revenue EstimatesZacks Investment Research • 11/03/21
Solid Biosciences Provides Third Quarter 2021 Business Update and Financial ResultsGlobeNewsWire • 11/03/21
Pathway Development Consortium Releases Draft White Paper to Facilitate AAV Gene Therapy DevelopmentGlobeNewsWire • 11/02/21
Solid Biosciences to Participate at the Jefferies Gene Therapy/Editing SummitGlobeNewsWire • 10/21/21
Solid Biosciences and Forge Biologics Announce Viral Vector Contract Development and cGMP Manufacturing PartnershipBusiness Wire • 10/04/21
Solid Biosciences Reports Additional Pulmonary Function Results from the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001GlobeNewsWire • 09/29/21
Solid Biosciences Reports 1.5-Year Data from Patients in the Ongoing IGNITE DMD Phase I/II Clinical Trial of SGT-001GlobeNewsWire • 09/23/21
Implied Volatility Surging for Solid Biosciences (SLDB) Stock OptionsZacks Investment Research • 09/22/21
SLDB Stock Alert: Dear Solid Biosciences Investors, Mark Your Calendar for Sept. 23!InvestorPlace • 09/21/21